{"news1": "The pharma company\u2019s net profit rose 9.9% YoY to \u20b9801 crore. This growth was supported by a 6% rise in the revenue to \u20b95,810 crore. The management said that the company\u2019s Q3FY23 performance reflects sustained momentum in core One-India and US businesses. : ", "news2": "In the December quarter, Fevicol maker\u2019s net profit declined 14% YoY to \u20b9307 crore. In the same period, the company\u2019s net sales rose 5% to \u20b92,987 crore. The management observed that while the input prices have moderated, this is yet to reflect in the gross margins (profitability) as the company is consuming high priced inventory in this quarter. : ", "news3": "Adani Enterprises\u2019 \u20b920,000 crore Follow-on Public Offer (FPO) will open for subscription today. The company plans to use the FPO proceeds for investing in the business and paring debt. Click here to apply for the FPO on Upstox. : Global markets (at 8:30 AM today)"}